Triflunordazepam
From Wikipedia, the free encyclopedia
Jump to: navigation, search
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
5-phenyl-7-(trifluoromethyl)-1,3-dihydro-1,4-benzodiazepin-2-one
|
|
| Identifiers | |
| CAS Number | 2285-16-7  Y |
| ATC code | none |
| PubChem | CID 16795 |
| Chemical data | |
| Formula | C16H11F3N2O |
| Molar mass | 304.267 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
| (verify) | |
Triflunordazepam (also known as Ro5-2904)[1] is a drug which is a benzodiazepine derivative with high GABAA receptor affinity, and has anticonvulsant effects.[2][3]
See also[edit]
References[edit]
- ^ DE Patent 1136709
- ^ Archives Internationales de Pharmacodynamie et de Thérapie. (1965). Vol 154, p 131.
- ^ So SS, Karplus M (December 1996). "Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors". Journal of Medicinal Chemistry. 39 (26): 5246–56. doi:10.1021/jm960536o. PMID 8978853.
 |
This sedative-related article is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
